Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Shares Outstanding (Entity) of $32.0 million for Q1 2026, up 4.38% year-over-year from $30.7 million in Q1 2025, and little changed quarter-over-quarter from $32.0 million in Q4 2025.
Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $32.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 4.38% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $32.0 million (up 4.38% YoY), while the FY2025 annual figure was $32.0 million, up 4.17% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $32.0 million, roughly flat from $32.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $32.0 million in Q1 2026, with the low at $185084.0 in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $30.4 million (2024), against an average of $19.3 million.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) jumped 16321.41% in 2024, then increased 0.93% in 2025.
- Sagimet Biosciences' Shares Outstanding (Entity) stood at $185084.0 in 2022, then soared by 5551.67% to $10.5 million in 2023, then surged by 193.25% to $30.7 million in 2024, then gained by 4.17% to $32.0 million in 2025, then increased by 0.2% to $32.0 million in 2026.
- Business Quant data shows SGMT's Shares Outstanding (Entity) at $32.0 million in Q1 2026, $32.0 million in Q4 2025, and $31.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | 53.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.11 Mn |
| Mar 31, 2026 | 32.56 Mn |
| Dec 31, 2025 | 32.35 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Jun 30, 2025 | 32.20 Mn |
| Mar 31, 2025 | 32.20 Mn |
| Dec 31, 2024 | 31.35 Mn |
| Sep 30, 2024 | 32.14 Mn |
| Jun 30, 2024 | 31.91 Mn |
| Mar 31, 2024 | 29.04 Mn |
| Dec 31, 2023 | 10.46 Mn |
| Sep 30, 2023 | 18.19 Mn |
| Jun 30, 2023 | 189,520.00 |
| Mar 31, 2023 | 185,137.00 |
| Dec 31, 2022 | 184,619.00 |
| Sep 30, 2022 | 185,084.00 |
| Jun 30, 2022 | 185,084.00 |